Increased cancer risk for individuals with a family history of prostate cancer, colorectal cancer, and melanoma and their associated screening recommendations and practices

Cancer Causes and Control

Volumn 19, Issue 1, 2008, Pages 1-12

  Noe, Megan ^a   Schroy, Paul ^b   Demierre, Marie France ^b   Babayan, Richard ^b   Geller, Alan C ^b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Colon cancer; Family history; Melanoma; Prostate cancer; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

CANCER SCREENING; COLORECTAL CANCER; FAMILY HISTORY; GENETIC DISORDER; HUMAN; MEDICAL PRACTICE; MELANOMA; OCCULT BLOOD; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; RISK FACTOR;

COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; MELANOMA; PEDIGREE; PROSTATIC NEOPLASMS; RISK FACTORS; SKIN NEOPLASMS;

EID: 38149084780     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-007-9064-y     Document Type: Review

References (158)

1. Hemminki K, Czene K (2002) Attributable risks of familial cancer from the Family-Cancer Database. Cancer Epidemiol Biomarkers Prev 11(12):1638-16444
2. Kerber RA, O'Brien E (2005) A cohort study of cancer risk in relation to family histories of cancer in the Utah population database. Cancer 103(9):1906-1915
3. Ries L, Harkins D, Krapcho M et al (eds) SEER Cancer Statistics Review, 1975-2003. National Cancer Institute. Bethesda, MD: http://seer.cancer.gov/csr/ 1975_2003/, based on November 2005 SEER data submission, posted to the SEER web site, 2006
4. Pinsky PF, Kramer BS, Reding D, Buys S (2003) Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Am J Epidemiol 157(9):792-799
5. Matakidou A, Eisen T, Houlston RS (2005) Systematic review of the relationship between family history and lung cancer risk. Br J Cancer 93(7):825-833
6. Stratton JF, Pharoah P, Smith SK, Easton D, Ponder BA (1998) A systematic review and meta-analysis of family history and risk of ovarian cancer. Br J Obstet Gynaecol 105(5):493-499
7. Kerber RA, Slattery ML (1995) The impact of family history on ovarian cancer risk. The Utah Population Database. Arch Intern Med 155(9):905-912
8. Khoury-Collado F, Bombard AT (2004) Hereditary breast and ovarian cancer: what the primary care physician should know. Obstet Gynecol Surv 59(7):537-542
9. Kuhl CK, Kuhn W, Schild H (2005) Management of women at high risk for breast cancer: new imaging beyond mammography. Breast 14(6):480-486
10. Thull DL, Vogel VG (2004) Recognition and management of hereditary breast cancer syndromes. Oncologist 9(1):13-24
11. Antoniou AC, Easton DF (2006) Risk prediction models for familial breast cancer. Future Oncol 2(2):257-274
12. Watson EK, Henderson BJ, Brett J, Bankhead C, Austoker J (2005) The psychological impact of mammographic screening on women with a family history of breast cancer-a systematic review. Psychooncology 14(11):939-948
13. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA (1997) Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 71(5):800-809
14. Hsing AW, Chokkalingam AP (2006) Prostate cancer epidemiology. Front Biosci 11:1388-1413
15. Bruner DW, Moore D, Parlanti A, Dorgan J, Engstrom P (2003) Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer 107(5):797-803
16. Johns LE, Houlston RS (2003) A systematic review and meta-analysis of familial prostate cancer risk. BJU Int 91(9):789-794
17. Zeegers MP, Jellema A, Ostrer H (2003) Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma: a meta-analysis. Cancer 97(8):1894-1903
18. Sacco E, Prayer-Galetti T, Pinto F et al (2005) Familial and hereditary prostate cancer by definition in an Italian surgical series: clinical features and outcome. Eur Urol 47(6):761-768
19. Valeri A, Azzouzi R, Drelon E et al (2000) Early-onset hereditary prostate cancer is not associated with specific clinical and biological features. Prostate 45(1):66-71
20. Bratt O (2002) Hereditary prostate cancer: clinical aspects. J Urol 168(3):906-913
21. Bratt O, Kristoffersson U, Lundgren R, Olsson H (1999) Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study. Eur J Cancer 35(2):272-277
22. Hemminki K, Dong C (2000) Familial prostate cancer from the family-cancer database. Eur J Cancer 36(2):229-234
23. Keetch DW, Rice JP, Suarez BK, Catalona WJ (1995) Familial aspects of prostate cancer: a case control study. J Urol 154(6):2100-2102
24. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC (1992) Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA 89(8):3367-3371
25. Carter BS, Bova GS, Beaty TH et al (1993) Hereditary prostate cancer: epidemiologic and clinical features. J Urol 150(3):797-802
26. Gronberg H, Wiklund F, Damber JE (1999) Age specific risks of familial prostate carcinoma: a basis for screening recommendations in high risk populations. Cancer 86(3):477-483
27. Negri E, Pelucchi C, Talamini R et al (2005) Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia. Int J Cancer 114(4):648-652
28. Staples MP, Giles GG, English DR et al (2003) Risk of prostate cancer associated with a family history in an era of rapid increase in prostate cancer diagnosis (Australia). Cancer Causes Control 14(2):161-166
29. Lesko SM, Rosenberg L, Shapiro S (1996) Family history and prostate cancer risk. Am J Epidemiol 144(11):1041-1047
30. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC (1990) Family history and the risk of prostate cancer. Prostate 17(4):337-347
31. Leavy J, Ambrosini G, Fritschi L (2006) Vietnam military service history and prostate cancer. BMC Public Health 6:75
32. Cerhan JR, Parker AS, Putnam SD et al (1999) Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev 8(1):53-60
33. Hayes RB, Liff JM, Pottern LM et al (1995) Prostate cancer risk in U.S. blacks and whites with a family history of cancer. Int J Cancer 60(3):361-364
34. Monroe KR, Yu MC, Kolonel LN et al (1995) Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat Med 1(8):827-829
35. Narod SA, Dupont A, Cusan L et al (1995) The impact of family history on early detection of prostate cancer. Nat Med 1(2):99-101
36. Schuurman AG, Zeegers MP, Goldbohm RA, van den Brandt PA (1999) A case-cohort study on prostate cancer risk in relation to family history of prostate cancer. Epidemiology 10(2):192-195
37. Verhage BA, Aben KK, Witjes JA, Straatman H, Schalken JA, Kiemeney LA (2004) Site-specific familial aggregation of prostate cancer. Int J Cancer 109(4):611-617
38. Ghadirian P, Howe GR, Hislop TG, Maisonneuve P (1997) Family history of prostate cancer: a multi-center case-control study in Canada. Int J Cancer 70(6):679-681
39. Gronberg H, Damber L, Damber JE (1996) Familial prostate cancer in Sweden. A nationwide register cohort study. Cancer 77(1):138-143
40. Hemminki K, Czene K (2002) Age specific and attributable risks of familial prostate carcinoma from the family-cancer database. Cancer 95(6):1346-1353
41. Cunningham GR, Ashton CM, Annegers JF, Souchek J, Klima M, Miles B (2003) Familial aggregation of prostate cancer in African-Americans and white Americans. Prostate 56(4):256-262
42. Stone SN, Hoffman RM, Tollestrup K, Stidley CA, Witter JL, Gilliland FD (2003) Family history, Hispanic ethnicity, and prostate cancer risk. Ethn Dis 13(2):233-239
43. United States Preventive Services Task Force. Screening for Prostate Cancer: Recommendations and Rationale: Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/3rduspstf/prostatescr/ prostaterr.htm
44. Albertsen PC (2005) Prostate-specific antigen: how to advise patients as the screening debate continues. Cleve Clin J Med 72(6):521-527
45. Harris R, Lohr KN (2002) Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 137(11):917-929
46. Ankerst DP, Thompson IM (2006) Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification. Arch Ital Urol Androl 78(4):125-129
47. Ross KS, Guess HA, Carter HB (2005) Estimation of treatment benefits when PSA screening for prostate cancer is discontinued at different ages. Urology 66(5):1038-1042
48. Ross KS, Carter HB, Pearson JD, Guess HA (2000) Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection. Jama 284(11):1399-1405
49. Toubert ME, Guillet J, Chiron M et al (1996) Percentage of free serum prostate-specific antigen: a new tool in the early diagnosis of prostatic cancer. Eur J Cancer 32A(12):2088-2093
50. Schroder FH, Denis LJ, Roobol M et al (2003) The story of the European randomized study of screening for prostate cancer. BJU Int 92(Suppl 2):1-13
51. Matikainen MP, Schleutker J, Morsky P, Kallioniemi OP, Tammela TL (1999) Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk prostate cancer families. Clin Cancer Res 5(6):1275-1279
52. McWhorter WP, Hernandez AD, Meikle AW et al (1992) A screening study of prostate cancer in high risk families. J Urol 148(3):826-828
53. Sartor O (1996) Early detection of prostate cancer in African-American men with an increased familial risk of disease. J La State Med Soc 148(4):179-185
54. Shelton JB, Barocas DA, Conway F et al (2005) Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies. Urology 65(5):931-936
55. Valeri A, Cormier L, Moineau MP et al (2002) Targeted screening for prostate cancer in high risk families: early onset is a significant risk factor for disease in first degree relatives. J Urol 168(2):483-487
56. Cormier L, Kwan L, Reid K, Litwin MS (2002) Knowledge and beliefs among brothers and sons of men with prostate cancer. Urology 59(6):895-900
57. Arar N, Thompson I, Sarosdy M et al (2000) Risk perceptions among patients and their relatives regarding prostate cancer and its heredity. Prostate Cancer Prostatic Dis 3(3):176-185
58. Miller SM, Diefenbach MA, Kruus LK, Watkins-Bruner D, Hanks GE, Engstrom PF (2001) Psychological and screening profiles of first-degree relatives of prostate cancer patients. J Behav Med 24(3):247-258
59. Taylor KL, DiPlacido J, Redd WH, Faccenda K, Greer L, Perlmutter A (1999) Demographics, family histories, and psychological characteristics of prostate carcinoma screening participants. Cancer 85(6):1305-1312
60. Beebe-Dimmer JL, Wood DP Jr, Gruber SB et al (2004) Risk perception and concern among brothers of men with prostate carcinoma. Cancer 100(7):1537-1544
61. Bratt O, Damber JE, Emanuelsson M et al (2000) Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. Eur J Cancer 36(2):235-241
62. Bratt O, Emanuelsson M, Gronberg H (2003) Psychological aspects of screening in families with hereditary prostate cancer. Scand J Urol Nephrol 37(1):5-9
63. Cormier L, Reid K, Kwan L, Litwin MS (2003) Screening behavior in brothers and sons of men with prostate cancer. J Urol 169(5):1715-1719
64. Merrill RM (2001) Demographics and health-related factors of men receiving prostate-specific antigen screening in Utah. Prev Med 33(6):646-652
65. Spencer BA, Babey SH, Etzioni DA et al (2006) A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma. Cancer 106(4):765-774
66. Sweetman J, Watson M, Norman A et al (2006) Feasibility of familial PSA screening: psychosocial issues and screening adherence. Br J Cancer 94(4):507-512
67. Jacobsen PB, Lamonde LA, Honour M, Kash K, Hudson PB, Pow-Sang J (2004) Relation of family history of prostate cancer to perceived vulnerability and screening behavior. Psychooncology 13(2):80-85
68. Bock CH, Peyser PA, Gruber SB, Bonnell SE, Tedesco KL, Cooney KA (2003) Prostate cancer early detection practices among men with a family history of disease. Urology 62(3):470-475
69. Close DR, Kristal AR, Li S, Patterson RE, White E (1998) Associations of demographic and health-related characteristics with prostate cancer screening in Washington State. Cancer Epidemiol Biomarkers Prev 7(7):627-630
70. Vadaparampil ST, Jacobsen PB, Kash K, Watson IS, Saloup R, Pow-Sang J (2004) Factors predicting prostate specific antigen testing among first-degree relatives of prostate cancer patients. Cancer Epidemiol Biomarkers Prev 13(5):753-758
71. Weinrich SP, Greiner E, Reis-Starr C, Yoon S, Weinrich M (1998) Predictors of participation in prostate cancer screening at worksites. J Community Health Nurs 15(2):113-129
72. Weinrich SP, Reynolds WA Jr, Tingen MS, Starr CR (2000) Barriers to prostate cancer screening. Cancer Nurs 23(2):117-121
73. Miesfeldt S, Jones SM, Cohn W et al (2000) Men's attitudes regarding genetic testing for hereditary prostate cancer risk. Urology 55(1):46-50
74. Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348(10):919-932
75. Baglietto L, Jenkins MA, Severi G et al (2006) Measures of familial aggregation depend on definition of family history: meta-analysis for colorectal cancer. J Clin Epidemiol 59(2):114-124
76. Butterworth AS, Higgins JP, Pharoah P (2006) Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 42(2):216-227
77. Strate LL, Syngal S (2005) Hereditary colorectal cancer syndromes. Cancer Causes Control 16(3):201-213
78. Aarnio M, Sankila R, Pukkala E et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 81(2):214-218
79. Bulow S, Faurschou Nielsen T, Bulow C, Bisgaard ML, Karlsen L, Moesgaard F (1996) The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register. Int J Colorectal Dis 11(2):88-91
80. Galle TS, Juel K, Bulow S (1999) Causes of death in familial adenomatous polyposis. Scand J Gastroenterol 34(8):808-812
81. Rustgi AK (1994) Hereditary gastrointestinal polyposis and nonpolyposis syndromes. N Engl J Med 331(25):1694-1702
82. Lipton L, Tomlinson I (2004) The multiple colorectal adenoma phenotype and MYH, a base excision repair gene. Clin Gastroenterol Hepatol 2(8):633-638
83. Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC (1994) A prospective study of family history and the risk of colorectal cancer. N Engl J Med 331(25):1669-1674
84. Karner-Hanusch J, Mittlbock M, Fillipitsch T, Herbst F (1997) Family history as a marker of risk for colorectal cancer: Austrian experience. World J Surg 21(2):205-209
85. St John DJ, McDermott FT, Hopper JL, Debney EA, Johnson WR, Hughes ES (1993) Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 118(10):785-790
86. Newcomb PA, Taylor JO, Trentham-Dietz A (1999) Interactions of familial and hormonal risk factors for large bowel cancer in women. Int J Epidemiol 28(4):603-608
87. Sandhu MS, Luben R, Khaw KT (2001) Prevalence and family history of colorectal cancer: implications for screening. J Med Screen 8(2):69-72
88. Negri E, Braga C, La Vecchia C et al (1998) Family history of cancer and risk of colorectal cancer in Italy. Br J Cancer 77(1):174-179
89. Carstensen B, Soll-Johanning H, Villadsen E, Sondergaard JO, Lynge E (1996) Familial aggregation of colorectal cancer in the general population. Int J Cancer 68(4):428-435
90. Johns LE, Kee F, Collins BJ, Patterson CC, Houlston RS (2002) Colorectal cancer mortality in first-degree relatives of early-onset colorectal cancer cases. Dis Colon Rectum 45(5):681-686
91. La Vecchia C, Negri E, Franceschi S, Gentile A (1992) Family history and the risk of stomach and colorectal cancer. Cancer 70(1):50-55
92. Stefansson T, Moller PH, Sigurdsson F, Steingrimsson E, Eldon BJ (2006) Familial risk of colon and rectal cancer in Iceland: evidence for different etiologic factors? Int J Cancer 119(2):304-308
93. Le Marchand L, Zhao LP, Quiaoit F, Wilkens LR, Kolonel LN (1996) Family history and risk of colorectal cancer in the multiethnic population of Hawaii. Am J Epidemiol 144(12):1122-1128
94. Hall NR, Bishop DT, Stephenson BM, Finan PJ (1996) Hereditary susceptibility to colorectal cancer. Relatives of early onset cases are particularly at risk. Dis Colon Rectum 39(7):739-743
95. Slattery ML, Kerber RA (1994) Family history of cancer and colon cancer risk: the Utah Population Database. J Natl Cancer Inst 86(21):1618-1626
96. Slattery ML, Levin TR, Ma K, Goldgar D, Holubkov R, Edwards S (2003) Family history and colorectal cancer: predictors of risk. Cancer Causes Control 14(9):879-887
97. Andrieu N, Launoy G, Guillois R, Ory-Paoletti C, Gignoux M (2004) Estimation of the familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study). Gut 53(9):1322-1328
98. Maire P, Morichau-Beauchant M, Drucker J, Barboteau MA, Barbier J, Matuchansky C (1984) Familial occurrence of cancer of the colon and the rectum: results of a 3-year case-control survey. Gastroenterol Clin Biol 8(1):22-27
99. Nelson RL, Davis FG, Sutter E, Sobin LH, Kikendall JW, Bowen P (1994) Body iron stores and risk of colonic neoplasia. J Natl Cancer Inst 86(6):455-460
100. Winawer SJ, Zauber AG, Gerdes H et al (1996) Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 334(2):82-87
101. Ahsan H, Neugut AI, Garbowski GC et al (1998) Family history of colorectal adenomatous polyps and increased risk for colorectal cancer. Ann Intern Med 128(11):900-905
102. Pignone M, Saha S, Hoerger T, Mandelblatt J (2002) Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 137(2):96-104
103. Smith RA, von Eschenbach AC, Wender R et al (2001) American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-testing for early lung cancer detection. CA Cancer J Clin 51(1):38-75, quiz 7-80
104. Winawer S, Fletcher R, Rex D et al (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124(2):544-560
105. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G (2000) Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343(3):162-168
106. de Jong AE, Nagengast FM, Kleibeuker JH et al (2006) What is the appropriate screening protocol in Lynch syndrome? Fam Cancer 7:7
107. American Cancer Society. Can colon and rectum cancer be found early? http://www.cancer.org/docroot/CRI/content/ CRI_2_4_3X_Can_colon_and_rectum_cancer_be_found_early.asp
108. Hay J, Coups E, Ford J (2006) Predictors of perceived risk for colon cancer in a national probability sample in the United States. J Health Commun 11(Suppl 1):71-92
109. Vernon SW, Myers RE, Tilley BC, Li S (2001) Factors associated with perceived risk in automotive employees at increased risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 10(1):35-43
110. Stark JR, Bertone-Johnson ER, Costanza ME, Stoddard AM (2006) Factors associated with colorectal cancer risk perception: the role of polyps and family history. Health Educ Res 26:26
111. Robb KA, Miles A, Wardle J (2004) Demographic and psychosocial factors associated with perceived risk for colorectal cancer. Cancer Epidemiol Biomarkers Prev 13(3):366-372
112. Seeff LC, Nadel MR, Klabunde CN et al (2004) Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 100(10):2093-2103
113. Manne S, Markowitz A, Winawer S et al (2002) Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol 21(1):3-15
114. Weitzman ER, Zapka J, Estabrook B, Goins KV (2001) Risk and reluctance: understanding impediments to colorectal cancer screening. Prev Med 32(6):502-513
115. Harris MA, Treloar CJ, Byles JE (1998) Colorectal cancer screening: discussions with first degree relatives. Aust N Z J Public Health 22(7):826-828
116. Lipkus IM, Skinner CS, Dement J et al (2005) Increasing colorectal cancer screening among individuals in the carpentry trade: test of risk communication interventions. Prev Med 40(5):489-501
117. Madlensky L, Esplen MJ, Gallinger S, McLaughlin JR, Goel V (2003) Relatives of colorectal cancer patients: factors associated with screening behavior. Am J Prev Med 25(3):187-194
118. Christman LK, Abdulla R, Jacobsen PB et al (2004) Colorectal cancer screening among a sample of community health center attendees. J Health Care Poor Underserved 15(2):281-293
119. Slattery ML, Kinney AY, Levin TR (2004) Factors associated with colorectal cancer screening in a population-based study: the impact of gender, health care source, and time. Prev Med 38(3):276-283
120. Ramji F, Cotterchio M, Manno M, Rabeneck L, Gallinger S (2005) Association between subject factors and colorectal cancer screening participation in Ontario, Canada. Cancer Detect Prev 29(3):221-226
121. Codori AM, Petersen GM, Miglioretti DL, Boyd P (2001) Health beliefs and endoscopic screening for colorectal cancer: potential for cancer prevention. Prev Med 33(2 Pt 1):128-136
122. Walsh JM, Posner SF, Perez-Stable EJ (2002) Colon cancer screening in the ambulatory setting. Prev Med 35(3):209-218
123. Harris MA, Byles JE (1997) A survey of screening compliance among first degree relatives of people with colon cancer in New South Wales. J Med Screen 4(1):29-34
124. Ko CW, Kreuter W, Baldwin LM (2002) Effect of Medicare coverage on use of invasive colorectal cancer screening tests. Arch Intern Med 162(22):2581-2586
125. Longacre AV, Cramer LD, Gross CP (2006) Screening colonoscopy use among individuals at higher colorectal cancer risk. J Clin Gastroenterol 40(6):490-496
126. Bleiker EM, Menko FH, Taal BG et al (2005) Screening behavior of individuals at high risk for colorectal cancer. Gastroenterology 128(2):280-287
127. Halbert CH, Lynch H, Lynch J et al (2004) Colon cancer screening practices following genetic testing for hereditary nonpolyposis colon cancer (HNPCC) mutations. Arch Intern Med 164(17):1881-1887
128. Rawl SM, Menon U, Champion VL, Foster JL, Skinner CS (2000) Colorectal cancer screening beliefs. Focus groups with first-degree relatives. Cancer Pract 8(1):32-37
129. Schroy PC 3rd, Barrison AF, Ling BS, Wilson S, Geller AC (2002) Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol 97(4):1031-1036
130. Grange F, Chompret A, Guilloud-Bataille M et al (1995) Comparison between familial and nonfamilial melanoma in France. Arch Dermatol 131(10):1154-1159
131. Gandini S, Sera F, Cattaruzza MS et al (2005) Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 41(14):2040-2059
132. Ford D, Bliss JM, Swerdlow AJ et al (1995) Risk of cutaneous melanoma associated with a family history of the disease. The International Melanoma Analysis Group (IMAGE). Int J Cancer 62(4):377-381
133. Pho L, Grossman D, Leachman SA (2006) Melanoma genetics: a review of genetic factors and clinical phenotypes in familial melanoma. Curr Opin Oncol 18(2):173-179
134. Begg CB, Hummer A, Mujumdar U et al (2004) Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control 15(9):957-965
135. Florell SR, Boucher KM, Garibotti G et al (2005) Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol 23(28):7168-7177
136. Fisher NM, Schaffer JV, Berwick M, Bolognia JL (2005) Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. J Am Acad Dermatol 53(3):393-406
137. Hornbuckle J, Culjak G, Jarvis E et al (2003) Patterns of metastases in familial and non-familial melanoma. Melanoma Res 13(1):105-109
138. Helfand M, Mahon SM, Eden KB, Frame PS, Orleans CT (2001) Screening for skin cancer. Am J Prev Med 20(3 Suppl):47-58
139. American Cancer Society. Melanoma: detection and symptoms. Available at: http://www3.cancer.org/cancerinfo/. Accessed August 1, 2006
140. Goldsmith LA, Koh HK, Bewerse BA et al (1996) Full proceedings from the National Conference to Develop a National Skin Cancer Agenda. American Academy of Dermatology and Centers for Disease Control and Prevention, Washington, DC, April 8-10, 1995. J Am Acad Dermatol 35(5 Pt 1):748-756
141. Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL (1996) Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 88(1):17-23
142. Carli P, De Giorgi V, Palli D et al (2003) Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma. Arch Dermatol 139(5):607-612
143. American Academy of Dermatology. Skin Cancer Net. http://www. skincarephysicians.com/skincancernet/index.html. Accessed August 1, 2006
144. Hansen CB, Wadge LM, Lowstuter K, Boucher K, Leachman SA (2004) Clinical germline genetic testing for melanoma. Lancet Oncol 5(5):314-319
145. Jackson A, Wilkinson C, Pill R (1999) Moles and melanomas-who's at risk, who knows, and who cares? A strategy to inform those at high risk. Br J Gen Pract 49(440):199-203
146. Geller AC, Emmons K, Brooks DR et al (2003) Skin cancer prevention and detection practices among siblings of patients with melanoma. J Am Acad Dermatol 49(4):631-638
147. Manne S, Fasanella N, Connors J, Floyd B, Wang H, Lessin S (2004) Sun protection and skin surveillance practices among relatives of patients with malignant melanoma: prevalence and predictors. Prev Med 39(1):36-47
148. Janda M, Youl PH, Lowe JB et al (2006) What motivates men age > or =50 years to participate in a screening program for melanoma? Cancer 107(4):815-823
149. Aitken JF, Janda M, Lowe JB et al (2004) Prevalence of whole-body skin self-examination in a population at high risk for skin cancer (Australia). Cancer Causes Control 15(5):453-463
150. Robinson JK, Fisher SG, Turrisi RJ (2002) Predictors of skin self-examination performance. Cancer 95(1):135-146
151. Saraiya M, Hall HI, Thompson T et al (2004) Skin cancer screening among U.S. adults from 1992, 1998, and 2000 National Health Interview Surveys. Prev Med 39(2):308-314
152. Geller AC, Emmons KM, Brooks DR et al (2006) A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer 10:10
153. Masri GD, Clark WH Jr, Guerry D, Halpern A, Thompson CJ, Elder DE (1990) Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 22(6 Pt 1):1042-1048
154. Vasen HF, Bergman W, van Haeringen A, Scheffer E, van Slooten EA (1989) The familial dysplastic nevus syndrome. Natural history and the impact of screening on prognosis. A study of nine families in the Netherlands. Eur J Cancer Clin Oncol 25(2):337-341
155. Weinstock MA, Martin RA, Risica PM et al (1999) Thorough skin examination for the early detection of melanoma. Am J Prev Med 17(3):169-175
156. Janda M, Youl PH, Lowe JB, Elwood M, Ring IT, Aitken JF (2004) Attitudes and intentions in relation to skin checks for early signs of skin cancer. Prev Med 39(1):11-18
157. Miller DR, Geller AC, Wyatt SW et al (1996) Melanoma awareness and self-examination practices: results of a United States survey. J Am Acad Dermatol 34(6):962-970
158. Geller AC, O'Riordan DL, Oliveria SA, Valvo S, Teich M, Halpern AC (2004) Overcoming obstacles to skin cancer examinations and prevention counseling for high-risk patients: results of a national survey of primary care physicians. J Am Board Fam Pract 17(6):416-423